Drug-induced changes in brain dopamine and their relation to parkinsonism.
D000818:Animals; D001479:Basal Ganglia / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002552:Cerebral Ventricles; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism* / Q000494:pharmacology; D004558:Electric Stimulation; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010477:Perfusion; D010640:Phenothiazines / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism; D009435:Synaptic Transmission
D010640:Phenothiazines; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D004298:Dopamine